XG005

DRUG2 trials

Sponsors

Xgene Pharmaceutical Group

Conditions

Pain

Phase 1

Phase 1 Pharmacokinetics, Safety, and Tolerability Study

CompletedNCT04067947

Xgene Pharmaceutical GroupPain

Start: 2019-07-08End: 2020-02-10Updated: 2020-02-20

Pharmacokinetics Study of XG005 Capsule

CompletedNCT04499209

Xgene Pharmaceutical GroupPain

Start: 2017-10-16End: 2018-03-19Updated: 2020-08-18